Air Liquide Medical Systems in the news

A UK regulator is investigating Vivisol's proposed acquisition of Air Liquide Healthcare's home oxygen services business due to potential competition concerns.

The global medical gases market is projected to grow from USD 7337.57 million in 2026 to USD 9140.68 million by 2035, driven by therapeutic demand and innovations in delivery and monitoring.

Air Liquide, a major industrial gases player, supplies diverse sectors like manufacturing and healthcare globally, with long-term contracts and a growing focus on hydrogen and clean energy.

The inhaled nitric oxide market is experiencing significant growth, driven by increasing pulmonary diseases and technological advancements in respiratory care.

Air Liquide is driving industrial and medical innovation through collaborative semiconductor materials development, battery technology, superconducting cooling systems, and AI-driven patient care solutions.

Air Liquide focuses on collaborative innovation across various industries, from semiconductor materials and EV batteries to superconductivity and medical devices, significantly leveraging AI to enhance product development and patient care.

Air Liquide is driving patient-centered innovation and sustainable medical gas solutions, expanding home healthcare services through acquisitions and contracts, and integrating AI to improve chronic illness management.

Air Liquide is acquiring NovaAir's Indian operations to expand its presence in the industrial gas market in India.

The mechanical ventilator market is expected to reach USD 15.12 billion by 2035, driven by technological advancements and rising respiratory diseases, with North America leading regional growth.

The Europe at-home respiratory care services market, driven by technology and chronic disease prevalence, is set to double to USD 31.15 billion by 2033.

The industrial oxygen market is forecast to surge from $82.9 billion in 2025 to $177.3 billion by 2035, propelled by diverse applications in medical, chemical, and metal sectors, and advancements in production and distribution technologies.

The inhaled nitric oxide delivery system market is experiencing significant growth, driven by an increasing prevalence of respiratory diseases, technological advancements, and rising awareness among healthcare professionals.

Global demand for portable home ventilators is increasing as respiratory diseases rise and healthcare shifts toward convenient, home-based mechanical ventilation solutions.

Air Liquide Medical Systems designs and manufactures ventilators for healthcare, working with medical professionals to innovate and source components primarily from France or Europe.

A specialized oxygen therapy program provides medical oxygen to rural healthcare facilities in developing regions.

The global cough assist devices market is projected to grow to USD 505.1 million by 2035, driven by respiratory illnesses, neuromuscular disorders, and an aging population, with Philips leading the market.

Air Liquide and Linde struck a deal with Unitaid to improve oxygen access in poorer nations, addressing shortages and high costs exacerbated by Covid-19.

Global medical gas leaders are facing pressure to address critical oxygen shortages in developing nations through emergency supply measures and infrastructure investment.

Air Liquide Medical Systems' Antony plant is running ventilator production at six times pre-pandemic levels due to sustained high demand amid Covid-19 resurgence.

A 30 million euro industrial mobilization led by Air Liquide produced 8,500 transport ventilators that medical experts deem unsuitable for treating severe COVID-19 cases in intensive care.